Geraldine Bebernitz

1.5k total citations
25 papers, 604 citations indexed

About

Geraldine Bebernitz is a scholar working on Oncology, Genetics and Epidemiology. According to data from OpenAlex, Geraldine Bebernitz has authored 25 papers receiving a total of 604 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 8 papers in Genetics and 8 papers in Epidemiology. Recurrent topics in Geraldine Bebernitz's work include Cytokine Signaling Pathways and Interactions (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Geraldine Bebernitz is often cited by papers focused on Cytokine Signaling Pathways and Interactions (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (8 papers) and Cytomegalovirus and herpesvirus research (7 papers). Geraldine Bebernitz collaborates with scholars based in United States, United Kingdom and Canada. Geraldine Bebernitz's co-authors include Y Gluzman, Ellen Z. Baum, Thomas R. Jones, Stephanos Ioannidis, Michael Zinda, Minwei Ye, Keiko Tabei, J D Hulmes, Marshall M. Siegel and Stuart H. Johnston and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Blood.

In The Last Decade

Geraldine Bebernitz

24 papers receiving 587 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Geraldine Bebernitz United States 15 228 175 139 117 94 25 604
Charles S. Craik United States 15 574 2.5× 121 0.7× 179 1.3× 141 1.2× 41 0.4× 16 1.0k
Timothy J. Colby United States 10 325 1.4× 141 0.8× 331 2.4× 98 0.8× 117 1.2× 12 1.1k
Jessica L. Bridgford Australia 9 308 1.4× 123 0.7× 116 0.8× 68 0.6× 64 0.7× 9 866
Xiu Yu United States 9 346 1.5× 137 0.8× 217 1.6× 92 0.8× 23 0.2× 11 839
Chen‐Chen Kan United States 12 604 2.6× 201 1.1× 241 1.7× 95 0.8× 57 0.6× 15 898
Norman Kairies Germany 7 607 2.7× 82 0.5× 207 1.5× 106 0.9× 54 0.6× 7 874
Alun Bermingham United States 13 526 2.3× 99 0.6× 151 1.1× 132 1.1× 68 0.7× 16 775
Dawn L. Hall United States 14 508 2.2× 234 1.3× 102 0.7× 105 0.9× 125 1.3× 16 930
Holly L. MacArthur United States 9 299 1.3× 100 0.6× 59 0.4× 28 0.2× 170 1.8× 10 606
Céline Schalk‐Hihi United States 12 378 1.7× 88 0.5× 171 1.2× 95 0.8× 46 0.5× 23 841

Countries citing papers authored by Geraldine Bebernitz

Since Specialization
Citations

This map shows the geographic impact of Geraldine Bebernitz's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Geraldine Bebernitz with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Geraldine Bebernitz more than expected).

Fields of papers citing papers by Geraldine Bebernitz

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Geraldine Bebernitz. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Geraldine Bebernitz. The network helps show where Geraldine Bebernitz may publish in the future.

Co-authorship network of co-authors of Geraldine Bebernitz

This figure shows the co-authorship network connecting the top 25 collaborators of Geraldine Bebernitz. A scholar is included among the top collaborators of Geraldine Bebernitz based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Geraldine Bebernitz. Geraldine Bebernitz is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kettle, Jason G., Qibin Su, Neil P. Grimster, et al.. (2017). Abstract 979: Discovery of the JAK1 selective kinase inhibitor AZD4205. Cancer Research. 77(13_Supplement). 979–979. 5 indexed citations
2.
Chen, Huawei, Geraldine Bebernitz, Kirsten Bell, et al.. (2017). Abstract 4046: Targeting jak/stat adaptive mechanism with jak1 inhibitor azd4205 reduces residual disease and prolongs benefit of osimertinib. Cancer Research. 77(13_Supplement). 4046–4046. 2 indexed citations
3.
Lamb, Michelle L., Bo Peng, Jon Read, et al.. (2013). Discovery of novel Jak2–Stat pathway inhibitors with extended residence time on target. Bioorganic & Medicinal Chemistry Letters. 23(10). 3105–3110. 17 indexed citations
4.
Woessner, Richard, Geraldine Bebernitz, Kirsten Bell, et al.. (2013). Abstract 931: Highly selective JAK1 kinase inhibitors suppress Y705-mediated STAT3 activation in a wide range of tumor types, with reduced hematological toxicity.. Cancer Research. 73(8_Supplement). 931–931.
5.
Wang, Tao, Stephanos Ioannidis, Lynsie Almeida, et al.. (2011). In vitro and in vivo evaluation of 6-aminopyrazolyl-pyridine-3-carbonitriles as JAK2 kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(10). 2958–2961. 12 indexed citations
6.
Ioannidis, Stephanos, Michelle L. Lamb, Lynsie Almeida, et al.. (2010). Replacement of pyrazol-3-yl amine hinge binder with thiazol-2-yl amine: Discovery of potent and selective JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1669–1673. 15 indexed citations
7.
Olson, Matthew W., Amar S. Prashad, Geraldine Bebernitz, et al.. (2009). Small molecule inhibitors of HIV RT Ribonuclease H. Bioorganic & Medicinal Chemistry Letters. 20(1). 398–402. 20 indexed citations
8.
Ioannidis, Stephanos, Michelle L. Lamb, Audrey M. Davies, et al.. (2009). Discovery of pyrazol-3-ylamino pyrazines as novel JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(23). 6524–6528. 21 indexed citations
9.
Scott, David A., Brian Aquila, Geraldine Bebernitz, et al.. (2008). Pyridyl and thiazolyl bisamide CSF-1R inhibitors for the treatment of cancer. Bioorganic & Medicinal Chemistry Letters. 18(17). 4794–4797. 14 indexed citations
10.
Gozgit, Joseph M., Geraldine Bebernitz, Minwei Ye, et al.. (2008). Effects of the JAK2 Inhibitor, AZ960, on Pim/BAD/BCL-xL Survival Signaling in the Human JAK2 V617F Cell Line SET-2. Journal of Biological Chemistry. 283(47). 32334–32343. 77 indexed citations
11.
Gozgit, Joseph M., Geraldine Bebernitz, Minwei Ye, et al.. (2007). Effects of a Novel, Selective Jak2 Inhibitor, AZ60, on STAT5 Signaling and Cellular Growth in Jak2 V617F Cell Lines.. Blood. 110(11). 3549–3549. 1 indexed citations
12.
Gopalsamy, Ariamala, John W. Ellingboe, Antonia A. Nikitenko, et al.. (2004). Design and Syntheses of 1,6-Naphthalene Derivatives as Selective HCMV Protease Inhibitors. Journal of Medicinal Chemistry. 47(8). 1893–1899. 13 indexed citations
13.
Grandi, Martin J. Di, Kevin J. Curran, Ellen Z. Baum, et al.. (2003). Pyrimido[1,2-b]-1,2,4,5-tetrazin-6-ones as HCMV protease inhibitors: a new class of heterocycles with flavin-like redox properties. Bioorganic & Medicinal Chemistry Letters. 13(20). 3483–3486. 13 indexed citations
14.
Siegel, Marshall M., Keiko Tabei, Geraldine Bebernitz, & Ellen Z. Baum. (1998). Rapid methods for screening low molecular mass compounds non-covalently bound to proteins using size exclusion and mass spectrometry applied to inhibitors of human cytomegalovirus protease. Journal of Mass Spectrometry. 33(3). 264–273. 36 indexed citations
15.
Baum, Ellen Z., Stuart H. Johnston, Geraldine Bebernitz, & Yakov Gluzman. (1996). Development of a Scintillation Proximity Assay for Human Cytomegalovirus Protease Using33Phosphorous. Analytical Biochemistry. 237(1). 129–134. 13 indexed citations
16.
Baum, Ellen Z., Marshall M. Siegel, Geraldine Bebernitz, et al.. (1996). Inhibition of Human Cytomegalovirus UL80 Protease by Specific Intramolecular Disulfide Bond Formation. Biochemistry. 35(18). 5838–5846. 20 indexed citations
17.
Jones, Thomas R., et al.. (1994). Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutants. Journal of Virology. 68(6). 3742–3752. 42 indexed citations
18.
Baum, Ellen Z., et al.. (1991). Purification, properties, and mutagenesis of poliovirus 3C protease. Virology. 185(1). 140–150. 35 indexed citations
19.
Bebernitz, Geraldine, et al.. (1990). Isolation of mutants of human immunodeficiency virus protease based on the toxicity of the enzyme in Escherichia coli.. Proceedings of the National Academy of Sciences. 87(14). 5573–5577. 47 indexed citations
20.
Montrose, Marshall H., Geraldine Bebernitz, & George A. Kimmich. (1985). Evaluation of ion gradient-dependent H+ transport systems in isolated enterocytes from the chick. The Journal of Membrane Biology. 88(1). 55–66. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Charles S. Craik Breakdown of academic impact, for papers by Timothy J. Colby Breakdown of academic impact, for papers by Jessica L. Bridgford Breakdown of academic impact, for papers by Xiu Yu Breakdown of academic impact, for papers by Chen‐Chen Kan Breakdown of academic impact, for papers by Norman Kairies Breakdown of academic impact, for papers by Alun Bermingham Breakdown of academic impact, for papers by Dawn L. Hall Breakdown of academic impact, for papers by Holly L. MacArthur Breakdown of academic impact, for papers by Céline Schalk‐Hihi
Rankless by CCL
2026